20 – 23 October 2026

AusBiotech International Conference 2026 | Early-Phase CRO for Biotechs

AusBiotech International Conference 2026 | Early-Phase CRO for Biotechs

AUSBIOTECH INTERNATIONAL Conference 2026

Event: AusBiotech International Conference 2026

Dates: 20–23 October 2026

Location: Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland

Attending: Avance Clinical, an award-winning full-service CRO and Australia’s leading early-phase specialist

Why: To discuss early-phase strategy, first-in-human planning, proof-of-concept milestones, and pathways into Asia and broader multi-regional development. Operational footprint includes key Asian hubs such as South Korea and Taiwan

Model: One CRO across Australia, Asia, and other key regions through Avance Clinical’s GlobalReady model

Action: Visit our booth or book a dedicated meeting with Avance Clinical, the leading Early Phase CRO in Australia

About Avance Clinical’s Early Phase Center of Excellence

As an award-winning leader in early-phase clinical research for more than 30 years, Avance Clinical helps biotechs build robust foundations for first-in-human trials and beyond, backed by deep therapeutic expertise and high-quality data.

Avance Clinical’s Early Phase Center of Excellence provides a streamlined pathway from preclinical to Phase I and proof-of-concept, with faster study startup in as little as 5–6 weeks from final protocol to study approval. It combines smarter protocol designs, multi-region regulatory support, and data and operational continuity across all trial phases to reduce delays and amendments while strengthening stakeholder and investor confidence.

Why Early Phase Biotechs Should Choose Avance Clinical’s
Early Phase Center
of Excellence

 

Expert Early Phase CRO in Australia

Through our Early Phase Centre of Excellence, our team combines smarter protocol design, global regulatory insight, and operational readiness from day one, helping reduce delays, limit rework, and build early-phase programs that are ready to scale from the start.

Seamless pathway from Australia early phase to Asia and beyond

Avance Clinical supports globally minded biotechs with an expanding operational footprint that includes key Asian hubs such as South Korea and Taiwan.

This access to diverse patient populations, regional scientific infrastructure, and accelerated clinical trial timelines allows Asia-based and global sponsors to leverage Australia’s early-phase advantages and R&D incentives, then scale efficiently into later-phase, multi-regional trials across the region and beyond.

One partner across Australia, Asia, China, and North America

Through our GlobalReady model, biotech sponsors work with a single CRO from first-in-human through later-phase, multi-country studies, with aligned teams, harmonised processes, and consistent data standards across Australia, Asia, and other key regions.

This reduces handoffs, preserves program knowledge, and supports more confident decisions as you move from proof-of-concept into larger, later-phase trials.

Therapeutic depth where it matters most

Our early-phase leadership is strengthened by therapeutic Centres of Excellence in Renal & Metabolic, CNS, and Oncology, as well as experience across more than 250 therapeutic indications.

Our expertise in complex programs helps biotechs translate strong science into high-quality clinical data every step of the way.

Meet Avance Clinical at AusBiotech 2026

Meet our team on the Gold Coast to discuss your next early-phase milestone, first-in-human strategy, or broader development pathway, whether you are an Asia-based biotech looking to access Australian early-phase advantages or a global sponsor planning multi-regional expansion.

Visit us at the conference or contact us using the form below to arrange a dedicated meeting.

Frequently Asked Questions

Yes. Avance Clinical is exhibiting at AusBiotech International Conference 2026, taking place from 20–23 October 2026 at the Gold Coast Convention & Exhibition Centre in Queensland.

Biotechs can meet with Avance Clinical to discuss early-phase strategy, first-in-human and proof-of-concept planning, and pathways into Asia and broader multi-regional development.

Avance Clinical combines Australia’s early-phase advantages with an expanding operational footprint in Asia, including key hubs such as South Korea and Taiwan, to help sponsors scale into later-phase, multi-regional studies.

Avance Clinical’s therapeutic Centres of Excellence include Renal & Metabolic, CNS, and Oncology, supported by experience across more than 250 therapeutic indications.

Book a meeting

Book a meeting - Generic
Terms and conditions

Related Events